Back to CVE records
Medium 6.5HealthcarePublished Mar 25, 2026

CVE-2026-32120OpenEMR has IDOR in Fee Sheet Product Save

Updated under an hour ago ()

Does this affect you?

It affects openemr and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.38%, higher than 30% of scored CVEs.

OpenEMR is a free and open source electronic health records and medical practice management application. Prior to version 8.0.0.3, an Insecure Direct Object Reference (IDOR) vulnerability in the fee sheet product save logic (`library/FeeSheet.class.php`) allows any authenticated user with fee sheet ACL access to delete, modify, or read `drug_sales` records belonging to arbitrary patients by manipulating the hidden `prod[][sale_id]` form field. The `save()` method uses the user-supplied `sale_id` in five SQL queries (SELECT, UPDATE, DELETE) without verifying that the record belongs to the current patient and encounter. Version 8.0.0.3 contains a patch.

CVSS
6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
Weakness (CWE)
CWE-639
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.38% (percentile 30)
Assigned by
GitHub_M
NVD analysis
Analyzed
Record last updated
Mar 26, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
openemr openemr
openemr:openemr (from the name)
before 8.0.0.3
CNA record
open-emr openemr
open-emr:openemr
before 8.0.0.3
NVD

References

  • x-refsource-confirm, exploit, vendor-advisory
  • x-refsource-misc, patch
  • x-refsource-misc, product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.